Monday, January 17, 2022

Moderna Inc.'s vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks and the company expects to be able to share data with regulators around March, CEO Stephane Bancel said on Monday. "The vaccine is being finished ... it should be in the clinic in coming weeks. We are hoping in the March timeframe to be able to have data to share with regulators to figure out next steps," Bancel said at the World Economic Forum's virtual Davos Agenda conference. Moderna is also developing a single vaccine that combines a booster dose against COVID-19 with its experimental flu shot. Bancel said the best-case scenario was the combined ...

Keep on reading: Moderna CEO says data for Omicron-specific shot likely available in March
Sponsored Links : Snapchat Generator - Grab snapchat pass,photos,contacts and more for free.

Tiktok Booster - trends start here. Free Tiktok Followers, Likes, Views!

Resurge.com– The Resurge supplement is formulated to deliver fat-burning properties to help one lose weight in a short period.

0 comments:

Post a Comment

Search

Bookmark Us

Delicious Digg Facebook Favorites More Stumbleupon Twitter